Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Gosselin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Discovery Medicine|June 30, 2016
Engineering tolerance using biomaterials to target and control antigen presenting cellsLisa H Tostanoski, Emily A Gosselin, Christopher M Jewell
The AAPS Journal|May 10, 2017
Controlled Release of Second Generation mTOR Inhibitors to Restrain Inflammation in Primary Immune CellsEmily A Gosselin, Lisa H Tostanoski, Christopher M Jewell
Frontiers in Bioengineering and Biotechnology|March 1, 2021
Impact of Excipients on Stability of Polymer Microparticles for Autoimmune TherapyEmily A Gosselin, Maeesha Noshin, Sheneil K Black, et al.
Nature Materials|May 23, 2018
Designing natural and synthetic immune tissuesEmily A Gosselin, Haleigh B Eppler, Jonathan S Bromberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cellsJoshua M Gammon, Emily A Gosselin, Lisa H Tostanoski, et al.
Journal of Tissue Engineering and Regenerative Medicine|June 11, 2017
Multi-layered silk film coculture system for human corneal epithelial and stromal stem cellsEmily A Gosselin, Tess Torregrosa, Chiara E Ghezzi, et al.
Mbio|November 8, 2023
mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccinesDania Zhivaki, Emily A Gosselin, Debrup Sengupta, et al.
Biomaterials Science|July 7, 2022
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccinationJames I Andorko, Shannon J Tsai, Joshua M Gammon, et al.
Nature Communications|February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantationJoshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Discovery Medicine|June 30, 2016
Engineering tolerance using biomaterials to target and control antigen presenting cellsLisa H Tostanoski, Emily A Gosselin, Christopher M Jewell
The AAPS Journal|May 10, 2017
Controlled Release of Second Generation mTOR Inhibitors to Restrain Inflammation in Primary Immune CellsEmily A Gosselin, Lisa H Tostanoski, Christopher M Jewell
Frontiers in Bioengineering and Biotechnology|March 1, 2021
Impact of Excipients on Stability of Polymer Microparticles for Autoimmune TherapyEmily A Gosselin, Maeesha Noshin, Sheneil K Black, et al.
Nature Materials|May 23, 2018
Designing natural and synthetic immune tissuesEmily A Gosselin, Haleigh B Eppler, Jonathan S Bromberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cellsJoshua M Gammon, Emily A Gosselin, Lisa H Tostanoski, et al.
Journal of Tissue Engineering and Regenerative Medicine|June 11, 2017
Multi-layered silk film coculture system for human corneal epithelial and stromal stem cellsEmily A Gosselin, Tess Torregrosa, Chiara E Ghezzi, et al.
Mbio|November 8, 2023
mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccinesDania Zhivaki, Emily A Gosselin, Debrup Sengupta, et al.
Biomaterials Science|July 7, 2022
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccinationJames I Andorko, Shannon J Tsai, Joshua M Gammon, et al.
Nature Communications|February 8, 2023
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantationJoshua M Gammon, Sean T Carey, Vikas Saxena, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Pageof 1